Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma

Genes Chromosomes and Cancer

Volumn 21, Issue 4, 1998, Pages 298-307

  Monni, Outi ^a   Oinonen, Riikka ^b   Elonen, Erkki ^b   Franssila, Kaarle ^b   Teerenhovi, Lasse ^b   Joensuu, Heikki ^b   Knuutila, Sakari ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 3Q; CHROMOSOME DELETION; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPE; MALE; MANTLE CELL LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENE DOSAGE; HUMANS; LOSS OF HETEROZYGOSITY; LYMPHOMA, SMALL CLEAVED-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLOIDIES;

BLASTOIDEA;

EID: 0031958998     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U     Document Type: Article

References (51)

1. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogenously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707-1711.
2. Banks PM, Chan J, Weary ML, Delsol G, de Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke R (1992) Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16:637-640.
3. Bentz M, Huck K, du Manoir S, Joos S, Werner CA, Fioscer K, Döhner H, Lichter P (1995) Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 85:3610-3618.
4. Bentz M, Werner CA, Döhner H, Joos S, Barth TFK, Siebert R, Schröder M, Stilgenbauer S, Fischer K, Möller P, Lichter P (1996) High incidence of chromosomal imbalances und gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 88:1437-1444.
5. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124-2130.
6. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, lassies D, Jaffe ES, Montserrat E, Rozman C, Cardesa A (1994) PRAD-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 84:2726-2732.
7. Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM (1993) Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 3:67-72.
8. Davis M, Hitchcock A, Foulkes WD, Campbell IG (1996) Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56:741-744.
9. De Boer CJ, Loyson S, Kluin PM, Kluin-Nelemans HC, Schuuring E, van Krieken JHJM (1993) Multiple breakpoints within the BCL-1 locus in B-cell lymphomas: Rearrangements of the cyclin D1 gene. Cancer Res 53:4148-4152.
10. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154.
11. Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L, Dehaen M, Verhoef G, Thomas J, de Kelver W, Bakker-Schut T, Cassiman JJ, Raap AK, De Wolf-Peeters C, Van den Berghe H, Hagemeier A (1997) Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 11:747-758.
12. El-Rifai W, Knuutila S (1996) Fluorescent in situ hybridization on archival G-banded slides. Cytogenet Cell Genet 73:322-324.
13. Koulkes WD, Campbell IG, Stamp GWH, Trowsdale J (1993) Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 67:268-273.
14. Gaudrey P, Szepetowski P, Escot C, Birnbaum D, Theillet C (1992) DNA amplification at 11q13 in human cancer: From complexity to perplexity. Mutat Res 276:317-328.
15. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pedersen A, Anderson JR, Weisenburger DD (1996) P53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 87:4302-4310.
16. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle RMC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA (1994) Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumorsuppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
17. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, deary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361-1392.
18. Heim S, Mitelman F (1995) Cancer Cytogenetics, Second ed. New York: Wiley-Liss, Inc.
19. Houldsworth J, Mathew S, Ruo PH, Dyomina K, Louie DC, Parsa N, Offit K, Chuganti RSK (1996) REL proto-oncogene is frequently amplified in cxtranodal diffuse large cell lymphoma. Blood 87: 25-29.
20. ISCN (1995) An International System for Human Cytogenetic Nomenclature. Mitelman F (ed). Basel: S. Karger.
21. Jiang X, Hitchcock A, Bryan EJ, Watson RH, Englefield P, Thomas EJ, Campbell IG (1996) Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 56:3534-3539.
22. Joos S, Otano-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P, Lichter P (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87:1571-1578.
23. Kullioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors, Genes Chromosomes Cancer 10:231-243.
24. Karhu R, Knuutila S, Kallioniemi OP, Siitonen S, Aine R, Vilpo V, Vilpo J (1997) Frequent loss of the 11q14-q24 region in chronic lymphocytic leukemia - A study by comparative genomic hybridization. Genes Chromosomes Cancer 19:286-290.
25. Kerckaert JP, Deweindt C, Tilly H, Quiet' S, Leqoq G, Bastard C (1993) LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 5:66-70.
26. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES (1990) Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752-763.
27. Liu Y, Grander D, Söderhäll S, Juliusson G, Gahrton G, Einhorn S (1992) Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 4:250-256.
28. Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VVVS, Schluger A, Chaganti RSK (1995) P53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 86:2892-2899.
29. Lovec H, Grzeschiczek A, Kowalski MB, Möröy T (1994) Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 13:3487-3495.
30. Monni O, Joensuu H, Franssila K, Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma - Comparative genomic hybridization study. Blood 87:5269-5278.
31. Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S (1997) BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 90:1168-1174.
32. Neilson JR, Cai M, Bienz N, Leyland MJ (1995) Leukaemic mantle cell lymphoma with t(11;14) and trisomy 12 showing clinical features of stage A0 B cell chronic lymphocytic leukemia. J Clin Pathol Mol Pathol 48:M165-M166.
33. Norton AJ, Mathews J, Pappa V, Shamash J, Love S, Rohatiner AZS, Lister TA (1995) Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 6:249-256.
34. Nowotny H, Karlic H, Grüner H, Hirsch J, Vesely M, Nader A, Heinz R (1996) Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms. Ann Hematol 72:291-301.
35. Offit K, Changanti RSK (1991) Chromosomal aberrations in nonHodgkin's lymphoma: Biologic and clinical correlations. Hematol/ Oncol Clin North Am 5:853-869.
36. Offit K, Jhanwar SC, Ladanyi M, Filippa M, Filippa DA, Chaganti RSK (1991) Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer 3:189-201.
37. Pabst T, Schwaller J, Bellomo MJ, Oestreicher M, Mühlematter D, Tichelli A, Tobler A, Fey MF (1996) Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood 88:1026-1034.
38. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauterds F, Wattel E, Fenaux P (1995) P16 gene homosygous deletions in acute lymphoblastic leukemia. Blood 85:657-663.
39. Rimokh R, Berger F, Delsol G, Charrin C, Berthéas MF, Ffrench M, Garoscio M, Felman P, Coiffier B, Bryon PA, Rochet M, Gentilhomme O, Germain D, Magaud JP (1993) Rearrangements and overexprcssion of the BCL1\IPRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 81: 3063-3067.
40. Srivatsan ES, Misra BC, Venugopalan M, Wilczynski SP (1991) Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am J Hum Genet 49:868-877.
41. Stilgenbauer S, Liebisch P, James MR, Schröder M, Schlegelberger B, Fischer K, Bentz M, Lichter P, Döhner H (1996) Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 93:11837-11841.
42. Swerdlow SH, Habeshaw JA, Murray LJ, Dhaliwal HS, Lister TA, Stansfeld AG (1983) Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. Am J Pathol 113:181-197.
43. Tunigami A, Tokino T, Takita KI, Ueda M, Kasumi F, Nakamura Y (1992) Detailed analysis of an amplified region at chromosome 11q13 in malignant tumors. Genomics 13:21-24.
44. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM (1984) Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403-1406.
45. Weisenburger DD, Armitage JO (1996) Mantle cell lymphoma - An entity comes of age. Blood 87:4483-4494.
46. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A (1993) Chromosome 11 translocation breakpoints at the PRAD1/Cyclin D1 gene locus in ccntrocytic lymphoma. Leukemia 7:241-245.
47. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Elomaa I, Knuutila S (1997) Microsatellite markers as tools for characterization of DNA amplifications evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 93:33-38.
48. Xiao S, Li D, Corson JM, Vijg J, Fletcher JA (1995) Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 55:2968-2971.
49. Ye BH, Rao PH, Chaganti RSK, Dalla-Favera R (1993) Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 53:2732-2735.
50. Zucca E, Stein H, Coffier B (1994) European Lymphoma Task Force (ELTF): Report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 5:507-511.
51. Zucca E, Roggero K, Pinotti G, Pedrinis K, Cappella C, Venco A, Cavalli F (1995) Patterns of survival in mantle cell lymphoma. Ann Oncol 6:257-262.